Discontinued — last reported Q4 '17
Non-Current Assets
Indefinite-Lived Research and Development Assets
Abbott Indefinite-Lived Research and Development Assets increased by 16.7% to $902.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 16.7%, from $773.00M to $902.00M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ3 2015
Last reportedQ4 2017
How to read this metric
An increase indicates active investment in future technology, while a decrease may signal project completion or impairment.
Detailed definition
These are acquired in-process research and development (IPR&D) projects that have not yet reached technological feasibil...
Peer comparison
Common in technology and pharmaceutical sectors following M&A activity.
Metric ID:
indefinite_lived_rd_assetsHistorical Data
5 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $0.00 | $319.00M | $568.00M | $773.00M | $902.00M |
| QoQ Change | — | — | +78.1% | +36.1% | +16.7% |
| YoY Change | — | — | +78.1% | +36.1% | +16.7% |
Range$0.00 – $902.00M
Avg YoY Growth+43.6%
Median YoY Growth+36.1%
Current Streak3+ quarters growth
Indefinite-Lived Research and Development Assets at Other Companies
Frequently Asked Questions
- What is Abbott's indefinite-lived research and development assets?
- Abbott (ABT) reported indefinite-lived research and development assets of $902.00M in Q4 2025.
- How has Abbott's indefinite-lived research and development assets changed year-over-year?
- Abbott's indefinite-lived research and development assets increased by 16.7% year-over-year, from $773.00M to $902.00M.
- What does indefinite-lived research and development assets mean?
- The value of research projects acquired from other companies that are still in progress.